OBJECTIVE： To provide reference for rational use of enteral nutrition （EN） drugs. METHODS： The data of EN drugs used for inpatients during 2011-2015 was extracted from our hospital information system， and analyzed statistically in respects of consumption sum， DDDs and DDC， etc. RESULTS： From 2011 to 2015， the consumption sum and and DDDs of EN drugs for inpatients did not change significantly， and the consumption sum ratio of EN drugs kept about 40％ each year. The consumption sum of EN suspension （TPF） occupied the first place during 2011-2013 and 2015， and decreased to second place in 2014； that of EN emulsion （TPF-T） increased， pulling up from forth place to first or second place. DDDs of EN suspension （TPF） always dominated the first place； that of EN suspension （SP） decreased significantly， dropping from second place to fifth place during 2013-2014； that of EN emulsion （TPF-T） increased significantly， pulling up from fifth place to second place. Top 5 departments in the list of accumulative DDDs of EN in our hospital during 2011-2015 were  neurology department （containing cadre neurology department）， respiratory medicine department （containing cadre respiratory medicine department）， ICU， cadre digestive nephropathy department and cadre cardiology department， and constituent ratio of them were 27.5％， 18.1％， 15.3％， 11.8％ and 8.5％； total DDDs of EN in internal medicine department and ICU were much higher than that of surgical department. For some departments， the selection of EN drugs variety was not proper. CONCLUSIONS： The consumption of EN drugs is stable in our hospital， but it is not yet main clinical nutrition method， especially DDDs of EN drugs is in low level in surgical department.  The tendency of EN drugs use reflect that clinical use of multiple drugs become reasonable， but the selection of EN drugs variety is not proper in some department. Clinical pharmacists should further strengthen their awareness and clinical use of EN.